resectable pancreatic ductal adenocarcinoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

M.D. Anderson Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadneutrophil count

I am/have/hadplatelet count

I am/have/hadpancreatic adenocarcinoma

I am/have/hadceliac disease

I am/have/hadresectable pancreatic cancer

I am/have/hadcancer

I am/have/hadendoscopic ultrasound

I am/have/hadmetastasis

I am/have/hadpancreatic cancer

I am/have/hadadenocarcinoma

added new label for I am/have/had

more

I am looking for

I am looking forleucovorin

I am looking foroxaliplatin

I am looking forcisplatin

I am looking forfluorouracil

I am looking forgemcitabine

I am looking forcapecitabine

I am looking forpaclitaxel

I am looking foririnotecan

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

The purpose of this Phase I study is to determine the recommended phase 2 dose (RP2D) and safety profile of NBTXR3 activated by radiation therapy for the treatment of patients with pancreatic cancer that has spread to nearby tissues or lymph nodes (locally advanced) or may be able to be …

leucovorin

oxaliplatin

cisplatin

fluorouracil

gemcitabine

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.